“Best Practices for the Safe & Cost-Effective Management of Controlled Substances”
Event Navigation
Institute for Safe Medication Practices* presents…”Best Practices for the Safe & Cost-Effective Management of Controlled Substances”
This session will provide guidance to assess an organization’s medication-use processes for vulnerabilities and identify strategies that may improve the capacity to prevent or detect diversion. Speakers will discuss known diversion cases, vulnerabilities in the medication use process, literature, case studies, guidelines, as well as their personal experiences. They will review a recent study that quantified the drug and workforce waste cost and discuss the use of healthcare technologies as a mechanism to reduce the opportunity for diversion. Thorough system-based strategies that can broaden an organization’s response to diversion beyond that of individual accountability will be reviewed.
Learning Objectives | At the end of this session, participants should be able to:
- Identify practices that support medication safety and eliminate risk for drug diversion.
- Discuss interventions to minimize diversion of controlled substances.
- Recognize essential components of a diversion stewardship program.
- Recall quantifiable cost data associated with opioid waste.
Presenters:
John Hertig, PharmD, MS, CPPS | Associate Professor | Butler University College of Pharmacy and Health Sciences
Christina Michalek, BSc Pharm, RPh, FASHP | Medication Safety Specialist
Deborah Wagner, PharmD | Clinical Professor, Pharmacy | College of Pharmacy | Clinical Professor, Anesthesiology | Medical School | University of Michigan
Intended Audience: Pharmacists, Pharmacy Technicians, Medication Safety and Patient Safety Officers, Quality and Risk Management Leaders, Hospital and Health System Leadership, Nursing and Pharmacy Managers and Administrators, Nurses
Continuing Education:
This CE activity is jointly provided by ProCE, LLC and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-507-L05-P/T has been assigned to this knowledge-based live CE activity (initial release date October 22, 2020). This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com no later than November 20, 2020 is required to receive CE credit. CE credit will be automatically uploaded to NABP/CPE Monitor upon completion of the post-test and evaluation. No partial credit will be given. Conflict of interest disclosures are required of all faculty and shall be provided to all webinar participants.
Questions should be directed to Institute for Safe Medication Practices, (215) 947-7797
This activity is funded through an educational grant from Fresenius Kabi.
* NOTE: This is an industry and/or contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.
